Successful Treatment of Combined Large Cell Neuroendocrine Carcinoma Harboring an EGFR Mutation with <i>EGFR</i>-TKIs plus Bevacizumab: A Case Report.

Muto, Satoshi; Ozaki, Yuki; Okabe, Naoyuki; Matsumura, Yuki; Hasegawa, Takeo; Shio, Yutaka; Hashimoto, Yuko; Suzuki, Hiroyuki

Successful Treatment of Combined Large Cell Neuroendocrine Carcinoma Harboring an EGFR Mutation with EGFR-TKIs plus Bevacizumab: A Case Report.

Muto, Satoshi; Ozaki, Yuki; Okabe, Naoyuki; Matsumura, Yuki; Hasegawa, Takeo; Shio, Yutaka; Hashimoto, Yuko; Suzuki, Hiroyuki.

Afiliação

Muto S; Department of Chest Surgery, Fukushima Medical University, Fukushima, Japan.
Ozaki Y; Department of Chest Surgery, Fukushima Medical University, Fukushima, Japan.
Okabe N; Department of Chest Surgery, Fukushima Medical University, Fukushima, Japan.
Matsumura Y; Department of Chest Surgery, Fukushima Medical University, Fukushima, Japan.
Hasegawa T; Department of Chest Surgery, Fukushima Medical University, Fukushima, Japan.
Shio Y; Department of Chest Surgery, Fukushima Medical University, Fukushima, Japan.
Hashimoto Y; Department of Diagnostic Pathology, Fukushima Medical University, Fukushima, Japan.
Suzuki H; Department of Chest Surgery, Fukushima Medical University, Fukushima, Japan.

Case Rep Oncol ; 13(3): 1387-1392, 2020.

Article em En | MEDLINE | ID: mdl-33442360

Palavras-chave

Bevacizumab; Epidermal growth factor receptor mutation; Large cell neuroendocrine carcinoma; Tyrosine kinase inhibitors

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Case Rep Oncol Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Case Rep Oncol Ano de publicação: 2020 Tipo de documento: Article